Abeona Therapeutics
ABEO
100 hedge funds and large institutions have $188M invested in Abeona Therapeutics in 2025 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 38 increasing their positions, 24 reducing their positions, and 14 closing their positions.
322% more call options, than puts
Call options by funds: $8.67M | Put options by funds: $2.06M
58% more repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 24
36% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 14
5% more funds holding
Funds holding: 95 → 100 (+5)
1.17% more ownership
Funds ownership: 68.23% → 69.4% (+1.2%)
5% less capital invested
Capital invested by funds: $198M → $188M (-$10.3M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCC
Cable Car Capital
San Francisco,
California
|
+$3.81M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$3.7M |
| 3 |
Millennium Management
New York
|
+$2.87M |
| 4 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$2.57M |
| 5 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$2.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WSL
Western Standard LLC
Los Angeles,
California
|
-$5.34M |
| 2 |
BCM
Boone Capital Management
Atlanta,
Georgia
|
-$4.77M |
| 3 |
JP Morgan Chase
New York
|
-$3.48M |
| 4 |
Morgan Stanley
New York
|
-$2.29M |
| 5 |
LCM
Laurion Capital Management
New York
|
-$1.57M |
ABEO Hedge Fund Activity: Q3 2025 in Review
100 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Abeona Therapeutics (ABEO) for Q3 2025, worth a combined $188M — down 5.2% from $198M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new ABEO positions and 14 closed out — a net gain of 5 holders — while 38 added to existing stakes and 24 trimmed.
The largest buyer was Cable Car Capital, opening a new position worth an estimated $3.81M. The largest seller was Western Standard LLC, cutting an estimated $5.34M.
- 100 institutional investors held Abeona Therapeutics (ABEO) as of Q3 2025, up from 95 in Q2 2025.
- Funds reported $188M of Abeona Therapeutics stock for Q3 2025, down 5.2% quarter-over-quarter.
- 19 funds opened new Abeona Therapeutics positions in Q3 2025 and 14 closed out, a net change of +5 holders.
- The largest Abeona Therapeutics buyer in Q3 2025 was Cable Car Capital, an estimated $3.81M added.
- The largest Abeona Therapeutics seller in Q3 2025 was Western Standard LLC, an estimated $5.34M sold.
Based on aggregated 13F filings for Q3 2025.